Figure 1H primary data

Read full text
Authors: Marta Gaglia, Machika Kaku
Cited by: 0

Abstract

KSHV-negative BJAB cells were treated with 20 ng/mL TPA for 48 hours. Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”). BC3 cells treated with 20 ng/mL TPA and 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) were used as a positive control. IFN-β and IFN- λ1 mRNA levels were measured by RT-qPCR and normalized to 18S rRNA. They are plotted relative to the BC3 positive control

Fields of Study & Subjects

interferon and immune responses Viral-associated cancers and disorders NF-κB Signaling Pathways

Publication details

Journal / source
Figshare
Publication date
1 January 2026
Document type
Dataset